Continuous Outcome Model
Continuous Outcome Model - Related Videos
14:19
Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
0 Views •
Cited by 13 •
2016
Reliable and accurate outcome assessment is the key for translation of preclinical therapies into clinical treatment. The current paper describes how to assess three clinically relevant primary outcome parameters of cardiac performance and damage in a pig acute myocardial infarction model.
09:40
Batch and Continuous Bioreactors
0 Views •
2023
Bioreactors are used to grow organisms in large volumes, thereby enabling the production of mass quantities of the target product. These reactors can be batch reactors, which contain all of the components needed for cell growth, or continuous reactors, which have inlet and outlet ports allowing for the addition of fresh growth media and the removal of cell waste. This video presents batch and continuous reactors and demonstrates the use of bioreactors to grow bacteria in the laboratory.
04:08
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
0 Views •
2025
This protocol describes a procedure for inducing uterine injury in a mouse model, followed by downstream analyses during a subsequent pregnancy.
08:43
Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
0 Views •
Cited by 26 •
2015
Here we demonstrate the use of a wireless enabling technology for electroencephalogram (EEG) in neonatal rodent models of human disease. With telemetry, there are no encumbering connections, thus allowing natural behaviors.
01:12
Equation of Continuity
0 Views •
2023
Fluid motion is represented by either velocity vectors or streamlines. The volume of a fluid flowing past a given location through an area during a period of time is called the flow rate Q, or more precisely, the volume flow rate. Flow rate and velocity are related—for instance, a river has a greater flow rate if the velocity of the water in it is greater. However, the flow rate also depends on the size and shape of the river. The relationship between flow rate (Q) and average speed (v)...
FAQs
The model estimates how predictors relate to differences in a numerical medical response, while separately accounting for variation not explained by those predictors. This distinction helps researchers judge whether observed changes are associated with treatment or risk factors rather than simply reflecting differences among measurements. The result is an effect estimate that can be interpreted alongside its uncertainty.
Covariates provide additional patient or study characteristics that may be considered when estimating the relationship between a primary predictor and the outcome. Including them can help place treatment comparisons or risk-factor associations in a broader analytical context. Their use is especially relevant when researchers need to account for other measured factors while evaluating a medical response.
Effect magnitude describes how strongly a predictor is associated with a continuous outcome, whereas uncertainty indicates how precisely that association has been estimated. Considering both prevents researchers from focusing only on whether a difference exists. Together, they help clarify the practical size and reliability of observed therapeutic benefits, risk-factor relationships, or changes in disease-related measurements.
Researchers first identify the numerical response, such as a laboratory value, symptom score, or lung-function measurement, and specify the predictors of interest. They may also include relevant covariates, then estimate associations or differences and examine the resulting magnitude and uncertainty. The findings can subsequently be interpreted for treatment comparisons, risk-factor analysis, or changes over time.
This approach is useful when the outcome is recorded on a numerical scale and the amount of change matters. Blood pressure, laboratory values, symptom scores, and lung function can each provide more graded information than a simple category. Researchers can therefore quantify differences between treatment groups or associations with risk factors using the measured level of the response.
By relating predictors to repeated or time-associated numerical measurements, the analysis can help describe changes in patient-level outcomes and disease progression. In treatment studies, it can quantify differences between groups; in observational research, it can examine risk-factor associations. These results help researchers assess therapeutic benefits and interpret how medical measurements vary across patients or study conditions.